Clinical Trials Directory

Trials / Unknown

UnknownNCT02669485

The Impact of Indocyanine Green-enhanced Fluorescence Imaging on Bowel Transection in Left-sided Colorectal Resection

A Prospective Study to Investigate the Impact of Using Indocyanine Green-enhanced Fluorescence Imaging on the Location of Bowel Transection in Patients Undergoing Left-sided Colorectal Resection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of this study was to evaluate the impact of fluorescence imaging on the location of colorectal transection lines based on evaluation of perfusion with indocyanine green, how it's going to affect surgical planning and its possible benefits in reducing anastomotic leakage.

Detailed description

During surgery, the line of intended bowel transection would be determined by the surgeon. Then the anesthesiologist will administer a bolus of 5mg ICG intravenously (2.5mg/ml, 2ml), followed by 10ml normal saline flush. The perfusion of colon will be assessed via fluorescence angiography. The actual bowel transection, after ICG fluorescence study, would be compared with the intended bowel transection site. The difference in terms of distance and either more proximal or distal is recorded. Then bowel anastomosis is completed in the usual manner.

Conditions

Interventions

TypeNameDescription
DRUGindocyanine greenInjection of indocyanine green and using fluorescence imaging to assess perfusion of bowel before bowel transection and anastomosis
DEVICEFluorescence imaging

Timeline

Start date
2016-01-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2016-02-01
Last updated
2016-02-01

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT02669485. Inclusion in this directory is not an endorsement.